JP2015517982A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517982A5
JP2015517982A5 JP2014560096A JP2014560096A JP2015517982A5 JP 2015517982 A5 JP2015517982 A5 JP 2015517982A5 JP 2014560096 A JP2014560096 A JP 2014560096A JP 2014560096 A JP2014560096 A JP 2014560096A JP 2015517982 A5 JP2015517982 A5 JP 2015517982A5
Authority
JP
Japan
Prior art keywords
antibody
seq
binding fragment
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014560096A
Other languages
English (en)
Japanese (ja)
Other versions
JP6163502B2 (ja
JP2015517982A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/028667 external-priority patent/WO2013131001A1/en
Publication of JP2015517982A publication Critical patent/JP2015517982A/ja
Publication of JP2015517982A5 publication Critical patent/JP2015517982A5/ja
Application granted granted Critical
Publication of JP6163502B2 publication Critical patent/JP6163502B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014560096A 2012-03-02 2013-03-01 抗上皮細胞接着分子(EpCAM)抗体及びその使用方法 Active JP6163502B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261606220P 2012-03-02 2012-03-02
US61/606,220 2012-03-02
PCT/US2013/028667 WO2013131001A1 (en) 2012-03-02 2013-03-01 ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF

Publications (3)

Publication Number Publication Date
JP2015517982A JP2015517982A (ja) 2015-06-25
JP2015517982A5 true JP2015517982A5 (https=) 2016-06-23
JP6163502B2 JP6163502B2 (ja) 2017-07-12

Family

ID=49083343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014560096A Active JP6163502B2 (ja) 2012-03-02 2013-03-01 抗上皮細胞接着分子(EpCAM)抗体及びその使用方法

Country Status (6)

Country Link
US (1) US9187558B2 (https=)
EP (1) EP2819695B1 (https=)
JP (1) JP6163502B2 (https=)
CN (1) CN104168916B (https=)
TW (1) TWI485161B (https=)
WO (1) WO2013131001A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2726870B1 (en) 2011-06-29 2018-10-03 Academia Sinica The capture, purification and release of biological substance using a surface coating
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
EP3328897A1 (en) * 2015-07-31 2018-06-06 Sutro Biopharma, Inc. ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EPCAM ANTIBODIES
FI3377103T4 (fi) * 2015-11-19 2025-04-16 Revitope Limited Funktionaalinen vasta-ainefragmenttikomplementointi kaksikomponenttiselle järjestelmälle epätoivottujen solujen uudelleenohjattua tappamista varten
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
JP2019530431A (ja) 2016-07-26 2019-10-24 テッサ・セラピューティクス・プライベート・リミテッド キメラ抗原受容体
JP6433951B2 (ja) * 2016-08-09 2018-12-05 東芝デジタルソリューションズ株式会社 ネットワーク監視装置およびプログラム
US10787499B2 (en) 2017-02-13 2020-09-29 Regents Of The University Of Minnesota EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors
US20210324335A1 (en) * 2018-09-04 2021-10-21 Academia Sinica Medium composition and method for culturing mesenchymal stem cells
MX2021010857A (es) * 2019-03-11 2021-12-15 Janssen Biotech Inc Anticuerpos biespecificos anti-v(beta17)/anti-cd123.
KR102560876B1 (ko) * 2019-06-11 2023-07-28 바이오아트라, 인코퍼레이티드 조건부 활성 항-epcam 항체, 항체 단편, 이들의 면역접합체 및 이의 용도
CA3161565A1 (en) * 2019-11-14 2021-05-20 Academia Sinica Use of anti-epcam antibodies in cancer therapy
CN110950959B (zh) * 2020-02-25 2020-07-03 和铂医药(上海)有限责任公司 靶向EpCAM的抗体及其制备和应用
CN112094350B (zh) * 2020-06-01 2024-01-05 普众发现医药科技(上海)有限公司 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体
JP7570653B2 (ja) * 2020-08-19 2024-10-22 ▲蘇▼州易慕峰生物科技有限公司 ヒト化抗体、キメラ抗原受容体、核酸、ベクター、細胞及び応用
CA3205465A1 (en) * 2020-12-18 2022-06-23 Bioardis, Llc Epcam binding molecules and uses thereof
TWI754504B (zh) * 2020-12-25 2022-02-01 龍華科技大學 棉花棒棒體之膠體檢測系統及其檢測方法
AU2022297542A1 (en) * 2021-06-25 2024-01-04 Academia Sinica Combined cancer therapy with an epithelial cell adhesion molecule (epcam) inhibitor and a hepatocyte growth factor receptor (hgfr) inhibitor
EP4359447A4 (en) * 2021-06-25 2025-05-07 Academia Sinica CANCER COMBINATION THERAPY WITH AN EPITHELIAL CELL ADHESION MOLECULE (EPCAM) INHIBITOR AND A WNT INHIBITOR
JP7794605B2 (ja) * 2021-11-05 2026-01-06 シスメックス株式会社 抗体の製造方法及び抗体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI9809391B8 (pt) 1997-04-14 2021-05-25 Amgen Res Munich Gmbh processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
ES2282797T3 (es) * 1999-12-27 2007-10-16 Crucell Holland B.V. Anticuerpo monoclonal humano que une ep-cam y su uso en la terapia delcancer.
EP1383785B1 (en) * 2001-05-03 2011-03-16 Merck Patent GmbH Recombinant tumor specific antibody and use thereof
US20100311954A1 (en) * 2002-03-01 2010-12-09 Xencor, Inc. Optimized Proteins that Target Ep-CAM
US7696320B2 (en) * 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
WO2004106917A2 (de) * 2003-06-02 2004-12-09 Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag Verfahren zur selektion von epitopen zur immuntherapie
US20050180979A1 (en) * 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
WO2007008943A2 (en) * 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
US7521195B1 (en) * 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
CA2682296C (en) * 2007-04-04 2017-02-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anti-epcam antibody and uses thereof
JP2011193728A (ja) * 2008-07-17 2011-10-06 Murata Mfg Co Ltd EpCAMに結合能を有するペプチド
GB0909904D0 (en) * 2009-06-09 2009-07-22 Affitech As Product
WO2011032296A1 (en) * 2009-09-21 2011-03-24 Mount Sinai Hospital Methods and compositions for the diagnosis and treatment of thyroid cancer
US20110165161A1 (en) * 2009-12-23 2011-07-07 Shih-Yao Lin Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same
SG185100A1 (en) * 2010-05-04 2012-11-29 Paul Walfish Method for the diagnosis of epithelial cancers by the detection of epicd polypeptide

Similar Documents

Publication Publication Date Title
JP2015517982A5 (https=)
CN112154157B (zh) 抗ror1抗体及其用途
CN108026169B (zh) 抗人cd137的完全人抗体及其应用
JP6239503B2 (ja) 新規な抗cxcr4抗体並びに癌の検出および診断のためのその使用
JP2019511904A5 (https=)
CN112010978B (zh) TrkA的抗体及其应用
US10809263B2 (en) Antigenic composition for detecting auto-antibody with specific response to exosomal protein EIF3A, and method for diagnosing liver cancer using antigenic composition
US20230287128A1 (en) Antigen-binding proteins targeting kklc-1 shared antigen
WO2023025315A1 (zh) 抗b7-h3抗体、其制备方法及用途
JP6707660B2 (ja) 抗ポドカリキシン様タンパク質前駆体サブタイプ2モノクローナル抗体とその生成方法及び使用
Gellini et al. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing’s sarcoma tumor cells
AU2022223337A1 (en) Vegfa-binding molecules
JP6977105B2 (ja) Igf−1r抗体および癌の診断のためのその使用
KR20210126057A (ko) 암세포에 존재하는 케라틴 14(krt14)의 세포외 부분을 표적화함으로써 암을 치료하거나 예방하는 방법
JP7229503B2 (ja) CADM1v9認識抗体
TW202246321A (zh) 抗pt217 tau抗體
WO2019066617A2 (ko) 항 c-met 항체 및 이의 용도
JP7086607B2 (ja) Igf-1r抗体および癌の診断のためのその使用
JP2014516922A (ja) プレキシンb2活性の変調剤
CN112079928B (zh) 一种抗pd-l1的单克隆抗体
KR102688094B1 (ko) Cobll1 단백질 특이 항체 또는 이의 항원 결합 단편, 및 이의 용도
CN117157401A (zh) 针对胰腺癌干细胞的抗体
EA051051B1 (ru) Способ лечения или профилактики рака путем целенаправленного воздействия на внеклеточную часть кератина 14 (krt14), присутствующую на раковых клетках